All One Health Content – Page 125
-
NewsBlack individuals more likely to experience inequities in early diagnosis of Lyme disease
A new study reveals that black patients are more likely to have advanced stages of Lyme disease when clinically diagnosed and also experience a longer time before receiving antibiotic treatment for the condition.
-
NewsSilent carriers: long-standing SARS-CoV-2 RNA in respiratory vesicles
Studies exploring extracellular vesicles (EVs) have uncovered an important piece of information: SARS-CoV-2 RNA was present in EVs in individuals who tested negative via standard RT-PCR methods.
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsCOVID-19 vaccine candidates show robust boosting potential
Two COVID-19 vaccines have shown strong potential to be an improved approach for boosting immunity to SARS-CoV-2 variants according to interim results of a Phase 1 clinical trial.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsMade-to-order diagnostic tests may be on the horizon
Researchers have made a breakthrough in diagnostic technology, inventing a ‘lab on a chip’ that can be 3D-printed in just 30 minutes. The chip has the potential to make on-the-spot testing widely accessible.
-
NewsAdvanced MRI technology detects changes in the brain after COVID-19
Researchers have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people.
-
NewsNovel compounds promise success in the fight against tuberculosis and depression
Scientists have shown that a specific polyprenylated polycyclic acylphloroglucinol, PPAP53, is able to activate human macrophages to fight resistant tuberculosis bacteria without being toxic to the macrophages themselves.
-
OpinionCatch-22: the FDA, probiotics, and preterm infants
As the FDA issues warning letters about probiotic products sold for use in hospitalized preterm infants, families of babies threatened by necrotizing enterocolitis (NEC) now face a deadly Catch-22 situation.
-
NewsScientists find new, better way to develop vaccines
Researchers have developed a new system to display epitopes in mammal cells for immunization studies and believe that this method can help scientists greatly in immunization efforts.
-
NewsResearchers uncover new mechanism by which rotavirus induces diarrhea
Researchers report a new mechanism by which rotavirus induces diarrhea, interfering with the normal absorption of nutrients in the intestine.
-
FeaturesA gateway to health: harnessing gut microbiome biomarkers in breath for disease diagnosis and monitoring
Discover the immense potential of breath analysis to enhance our understanding of the gut microbiome.
-
NewsFermentation may have driven human brain evolution
While some have theorized that the use of fire and the invention of cooking gave our ancestors enough nourishment for our larger-brained ancestors to become dominant, a new theory points to a different spark - fermentation.
-
NewsT cells tackle new ‘Pirola’ SARS-CoV-2 variant
Scientists harness bioinformatics to predict how T cells may adapt to fighting the highly mutated Pirola variant.
-
NewsCovid persistence in lungs linked to failure of innate immunity
A new study shows that SARS-CoV-2 is found in the lungs of certain individuals for up to 18 months after infection, and that its persistence appears to be linked to a failure of innate immunity (the first line of defense against pathogens).
-
News Study reveals Zika’s shape-shifting machinery—and a possible vulnerability
Zika’s crucial enzyme performs multiple tasks, but a wrench in the system could bring it to a screeching halt.
-
NewsFirst results in using new tools to tackle respiratory syncytial virus
Vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent respiratory syncytial virus (RSV) among young children. Are those tools working?
-
News40 years after the discovery of HIV, research raises hopes of remission
The conference ’40 years of HIV science’ was an opportunity to look back at the major advances that are raising hopes of remission and a cure for HIV.
-
NewsNIH clinical trial of tuberculous meningitis drug regimen begins
A trial of a new drug regimen to treat tuberculous meningitis (TBM) has started enrolling adults and adolescents in several countries where tuberculosis (TB) is prevalent.
-
NewsNew study considers risks of colistin and carbapenem resistance posed by aquatic farms
Aquatic farms could serve as a potential reservoir of colistin and carbapenem resistance, a new study warns. The review, by researchers at the University of Manchester, ‘An Update on the Prevalence of Colistin and Carbapenem-Resistant Gram-Negative Bacteria in Aquaculture: an Emerging Threat to Public Health’, has been accepted by the ...